⌘K

Login Start Free

Home/Filings/4/0001250853-12-000098

4//SEC Filing

Wieland Douglas Scott 4

Accession 0001250853-12-000098

CIK 0000799698other

View on SEC.gov Company Profile

Filed

Dec 10, 7:00 PM ET

Accepted

Dec 11, 4:41 PM ET

Size

5.3 KB

Accession

0001250853-12-000098

Insider Transaction Report

Form 4

Period: 2012-12-10

Wieland Douglas Scott

Sr. VP - Drug Development

Transactions

Award
Stock Option(right to buy)
2012-12-10+100,000→ 100,000 total
Exercise: $1.83Exp: 2022-12-09→ Common Stock (100,000 underlying)

Footnotes (1)

[F1]Stock Option vests monthly for 36 months beginning January 10, 2013, provided Reporting Person remains in continuous employ of Issuer.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

CYTRX CORP

CIK 0000799698

Entity typeother

Related Parties

1

filerCIK 0001450614

Filing Metadata

Form type: 4
Filed: Dec 10, 7:00 PM ET
Accepted: Dec 11, 4:41 PM ET
Size: 5.3 KB

View on SEC.gov